During the past decade, Coastal Pulmonary and Critical Care conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coastal Pulmonary and Critical Care" #1 sponsor was "Actelion" with 1 trials, followed by "Galecto Biotech AB" with 1 trials sponsored, "Orinove, Inc." with 1 trials sponsored, "PureTech" with 1 trials sponsored and "United Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Pulmonary and Critical Care" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator, "Vanderbilt University" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Coastal Pulmonary and Critical Care" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Covid19" (1 trials), "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials), "Interstitial Lung Disease" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Coastal Pulmonary and Critical Care" in a lesser frequency.

Most popular intervention types in "Coastal Pulmonary and Critical Care" are "Drug" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "GB0139" (1 trials), "Inhaled Treprostinil" (1 trials), "LYT-100" (1 trials) and "Notapplicable" (1 trials). Other intervention names were less common.

The vast majority of trials in "Coastal Pulmonary and Critical Care" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Coastal Pulmonary and Critical Care". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Coastal Pulmonary and Critical Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Coastal Pulmonary and Critical Care, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".